HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Grötsch Selected Research

fonsartan

3/2003Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Grötsch Research Topics

Disease

1Atrophy
03/2003
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
03/2003
1Hypertension (High Blood Pressure)
03/2003
1Renal Hypertension
03/2003
1Ischemia
03/2003
1Sclerosis
03/2003
1Ventricular Fibrillation
03/2003
1Renal Insufficiency (Renal Failure)
03/2003

Drug/Important Bio-Agent (IBA)

1fonsartanIBA
03/2003
1Angiotensin IIIBA
03/2003
1Creatine Kinase (Creatine Phosphokinase)IBA
03/2003
1EnzymesIBA
03/2003
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2003
1Nitric Oxide Synthase (NO Synthase)IBA
03/2003
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
03/2003
1Lactic Acid (Lactate)FDA LinkGeneric
03/2003
1Losartan (Cozaar)FDA LinkGeneric
03/2003